Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.
14h
FOX 7 Austin on MSNMore Americans are turning to GLP-1 injections to lose weightMore and more Americans are turning to GLP-1 injections to lose weight. FOX 7 Austin's Rebecca Thomas spoke to an Austin physician to discuss.
Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.
After pre-announcing that its full-year revenue would come in below its original guidance, Eli Lilly (NYSE: LLY) announced ...
Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...
2hon MSN
Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.
In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...
21hon MSN
There’s no direct link between vision loss and taking the weight loss and diabetes drugs such as Ozempic, Wegovy, Mounjaro, ...
Warnings from experts indicate Ozempic and similar drugs such as Wegovy and Mounjaro can cause the critical medical condition ...
It’s obvious these drugs are trimming waistlines across the nation; what may be less obvious is that they might also reshape ...
If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS candidate RFK Jr told senators the GLP-1s are ‘miracle drugs’ but shouldn’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results